Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Prostate Specific Antigen (PSA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02703623
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
M.D. Anderson Cancer Center 196
Testing effectiveness (Phase 2)Study completedNCT00726596
What this trial is testing

Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 64
Large-scale testing (Phase 3)UnknownNCT00110162
What this trial is testing

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Peter MacCallum Cancer Centre, Australia 2,000
Not applicableEnded earlyNCT02771769
What this trial is testing

Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels

Who this might be right for
Prostatic Neoplasms
Chronix Biomedical Corporation 500
Early research (Phase 1)Ended earlyNCT00702923
What this trial is testing

CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 12
Not applicableActive Not RecruitingNCT04240327
What this trial is testing

Marker Driven Selection of Patients for Prostate Biopsy and Management

Who this might be right for
PSAElevated PSAProstate Cancer
University of Miami 289
Not applicableStudy completedNCT00694551
What this trial is testing

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT03503344
What this trial is testing

Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaPSA Progression+1 more
University of California, San Francisco 26
Testing effectiveness (Phase 2)Study completedNCT00148772
What this trial is testing

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Who this might be right for
Prostate Cancer
Endeavor Health 29
Not applicableUnknownNCT04599218
What this trial is testing

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

Who this might be right for
Prostate DiseaseElevated Prostate Specific AntigenFamily History of Prostate Cancer+2 more
Ardeshir Rastinehad 1,586
Testing effectiveness (Phase 2)Ended earlyNCT01681433
What this trial is testing

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Who this might be right for
Prostate CancerMetastatic Castrate-Resistant Prostate CancerPSA
Costantine Albany 72
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Testing effectiveness (Phase 2)Study completedNCT00165399
What this trial is testing

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Who this might be right for
Adenocarcinoma of the ProstateProstate Cancer
Dana-Farber Cancer Institute 62
Not applicableStudy completedNCT00243321
What this trial is testing

High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Virginia Commonwealth University 27
Testing effectiveness (Phase 2)Study completedNCT01521949
What this trial is testing

Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 21
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Testing effectiveness (Phase 2)Study completedNCT00004043
What this trial is testing

Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)UnknownNCT00731848
What this trial is testing

Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Roll International Corporation 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Not applicableNot Yet RecruitingNCT06669273
What this trial is testing

Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)

Who this might be right for
Suspected Prostate Cancer (increased PSA Level)
University Hospital, Clermont-Ferrand 70
Next Page